BRANFORD, Conn.–(BUSINESS WIRE)–Mar. 13, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 88,781 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity […]

BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 13, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 52,296 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity […]

BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 10, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the fourth quarter and full year 2025 on Tuesday, March 3, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, […]

BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 5, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced two new manuscripts have been released, one as a peer reviewed publication in the Journal of Analytical Chemistry and one via preprint on ChemRxiv. The preprint has also been […]

New library prep kit enables detection of proteins with as little as 1-2 ng of input Data analysis enhancements unlock new amino acid detection BRANFORD, Conn.–(BUSINESS WIRE)–Dec. 22, 2025– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the launch of the Version […]

BRANFORD, Conn.–(BUSINESS WIRE)–Dec. 15, 2025– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 39,920 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity […]

Expect Proteus launch by end of 2026 Demonstration of the detection of all 20 amino acids by end of 2026 New controlled cleavage chemistry unlocks path to billions of sequencing reads BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 20, 2025– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, […]

BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 19, 2025– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the key items to be presented at its Investor & Analyst Day that is being hosted in New York City. Among other advances, the management team will provide updates […]

Announces Successful Sequencing on Prototype Proteus Unit, Development Program Remains On-Track BRANFORD, Conn.–(BUSINESS WIRE)–Nov. 5, 2025– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the third quarter ended September 30, 2025. Press Release Highlights Reported revenue of $552,000 for […]

BRANFORD, Conn.–(BUSINESS WIRE)–Oct. 20, 2025– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will be participating in the CG MedTech, Diagnostics and Digital Health & Services Forum taking place Thursday, November 20, 2025 at the Westin NY Grand Central. Jeff […]